Roby Chen China

Humanwell is the market leader in anaesthetics/analgesics, fertility regulation drugs, and Uyghur medicine in Asia. It is also a major player with expanding product portfolio and market shares in treating central nerve system, respiratory and dermatological diseases in China.
Company Size (Fulltime employees)
Year of foundation
1993
Please specify your partnering goal
See above
Headquartner in China
Humanwell Healthcare
投资部经理 

Kevin Chen China

Wuxi Xinwu District
Partnering Objectives
Headquartner in China
Wuxi international life science innovation campus
Investment promotion manager 

Miss Ocean Chen China

Currently, TopWin Pharma. has developed to a high-tech group involving the biological and chemical medicine. TopWin Pharmaceutical Group's business has covered all aspects of R&D of new drugs, including clinical research, registration, production and sale. With the mission of "bringing benefits to mankind through innovation and technology", Topwin Group has been cooperating with well-known domestic and international drug R&D institutions to build TopWin Pharma. into a leading domestic and world-class pharmaceutical enterprise.
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
Oncology domain, clinical phase innovative project
Headquartner in China
Topwin pharma
BDM 

Suyuan Chen Germany

Our goal is to advance the development of analytical technologies by combining our specialist knowledge from chemistry, biology, physics and computer science and the transfer of our results to science, business and the public are our main goals.
Partnering Objectives
Headquartner in China
Leibniz-Institut fuer Analytische Wissenschaften - ISAS
Research associate 

Guofeng Cheng China

Biotech
Partnering Objectives
Headquartner in China
Biotech/Pharma Category
AusperBio
CEO 

Mr. Xinwei Cheng United States

Drug delivery antibody gene
Website:
www.luye.com
Company Size (Fulltime employees)
Year of foundation
2012
Partnering Objectives
Please specify your partnering goal
Looking for science and service
Headquartner in China
Luye Boston
Senior Scientists 
Functionality

Mr. Cliff Cheng China

A pharmaceutical company
Website:
www.buchang.com
Company Size (Fulltime employees)
Please specify your partnering goal
licensing-in and partnership
Headquartner in China
Buchang Pharma Group
CSO 

Wei Cheng

Public trade pharmaceutical company
Website:
Www.Fibrogen.com
Partnering Objectives
Headquartner in China
Fibrogen
Executive director 

Changfu Cheng United States

Dear Prospect Customer:

I would like to introduce my company (TDM Pharmaceutical Research, Inc) to you. TDM Pharmaceutical Research, INC, is a highly productive, intensely focused, quality-oriented CRO; we are experienced, well established, and driven by scientific merit. As a full-service GLP and GCP compliant laboratory, TDM offers a variety of discovery, research, development, bioanalytical, and consulting services to support discovery and development of pharmaceutical and chemical products. We pride ourselves on prompt data turnaround and addressing our clients’ needs with the accuracy and quality that are critical to their businesses.

TDM is uniquely different from other CROs: our over 90 years of combined industry experience allows us to resolve complex issues by providing comprehensive solutions in pharmacokinetics, toxicokinetics, pharmacokinetic/pharmacodynamic correlations, and more.

We are experienced in both the sponsor and the CRO position, so we anticipate and address the needs of our clients. Resourceful, committed personnel provide proactive support throughout each project, and respond to potential issues immediately.

Our myriad clients include both companies and individuals in the pharmaceutical and related industries. By selecting TDM as the partner for your next project, you will find we take each job and its needs personally; our focus is always on the client!

If you have any question, please feel free to contact me at: changfu.cheng@tdmrxresearch.com, or phone at 1-774-258-2425.

Thanks!

 

Changfu Cheng, PhD

President

TDM Pharmaceutical Research, Inc

https://tdmpharmalab.com

Company Size (Fulltime employees)
Year of foundation
1996
Please specify your partnering goal
IND of our drug candidates
Headquartner in China
Biotech/Pharma Category
Assets Information 1
FLUORINE- AND/OR DEUTERIUM-CONTAINING COMPOUNDS FOR TREATING NON-SMALL CELL LUNG CANCER AND RELATED DISEASES, US patent 10,633,367
Assets Information 2
DEUTERATED COMPOUNDS FOR TREATING FABRY, GAUCHER, PARKINSON’S AND RELATED DISEASES AND CONDITIONS, AND COMPOSITIONS AND METHODS THEREOF. US patent 10,519,157
Biotech/Pharma Asset Stage
Slides Deck
(pdf, 802.42KB)
TMD Pharmaceutical Research
President 
Functionality

Haipeng Cheng China

Sangel Capital provides venture capital and business finance to support high-tech enterprises in China and US. The firm seeks to invest in innovative startups in sectors including biopharma, diagnostics, medical devices, and biotech.
Sangel Capital was founded in 2010 and is based in Shenzhen, Beijing with additional offices in Suzhou and Chicago.
Sangel Capital